Clinical efficacy of mepolizumab in the treatment of severe eosinophilic asthma in children
Severe bronchial asthma in children remains a serious problem, which is caused by high mortality, side effects from therapy with high doses of glucocorticosteroids and a significant consumption of health resources. According to statistics from the Monitoring, Analysis and Strategic Health Developmen...
Main Authors: | V. N. Drozdov, A. A. Astapovskiy, S. Yu. Serebrova, E. V. Shikh, I. A. Komissarenko |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2020-11-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/5903 |
Similar Items
-
Efficacy of add-on mepolizumab in adolescents with severe eosinophilic asthma
by: Steven W. Yancey, et al.
Published: (2019-09-01) -
Severe eosinophilic asthma: from the pathogenic role of interleukin-5 to the therapeutic action of mepolizumab
by: Pelaia C, et al.
Published: (2017-10-01) -
Experience with mepolizumab in adults with severe eosinophilic asthma: a case series from India
by: Venkata Nagarjuna Maturu, et al.
Published: (2021-08-01) -
Real-life effectiveness of mepolizumab in patients with severe refractory eosinophilic asthma and multiple comorbidities
by: Claudia Crimi, et al.
Published: (2020-09-01) -
Patient profiles and clinical utility of mepolizumab in severe eosinophilic asthma
by: Haldar P
Published: (2017-06-01)